University of Michigan researchers developed an oral drug that can increase the ability of T cells to attack tumors.
To do so, they used 3,4-dihydroxybenzoic acid, or DHB, that is produced by gut bacteria.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.